Prenetics Global Limited (NASDAQ:PRENW) Sees Significant Decline in Short Interest

Prenetics Global Limited (NASDAQ:PRENW) was the target of a large decline in short interest during the month of February. As of February 13th, there was short interest totaling 1,740 shares, a decline of 14.7% from the January 29th total of 2,040 shares. Based on an average daily trading volume, of 2,725 shares, the days-to-cover ratio is presently 0.6 days. Based on an average daily trading volume, of 2,725 shares, the days-to-cover ratio is presently 0.6 days.

Prenetics Global Stock Down 2.6%

NASDAQ PRENW opened at $0.02 on Thursday. The firm’s fifty day moving average price is $0.03 and its 200 day moving average price is $0.03. Prenetics Global has a 12 month low of $0.01 and a 12 month high of $0.07.

About Prenetics Global

Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.

Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.